During the recent Annual Scientific Meeting 2024 in Hong Kong, organised by the Hong Kong Thoracic Society (HKTS) to put a focus on respiratory health, Professor Alyn Morice, head of Hull York Medical School’s respiratory department, shone a light on Peptest.

Professor Morice, a renowned expert in respiratory medicine and an expert in chronic cough, referenced Peptest’s role in reflux diagnosis during his presentation on ‘The Cause of Uncontrollable Asthma and Chronic Cough’ at the event.

Chronic cough is a cough in adults lasting for more than eight weeks. This persistent condition often poses diagnostic challenges, leading to prolonged discomfort and ineffective treatment.

Professor Morice’s procedures at Castle Hill Hospital’s renowned cough clinic, which serves approximately 5,000 patients from across Europe, includes using Peptest for diagnosing reflux-related issues in chronic cough.

Alyn Morice

Peptest, an immunological in-vitro diagnostic medical device, contains two pepsin monoclonal antibodies, enabling the identification of pepsin, a crucial marker in reflux-related conditions. It offers clinicians a reliable means to identify underlying issues contributing to respiratory symptoms.

Dr. Fanny Ko, chairman of the Hong Kong Lung Foundation, actively inaugurated the Annual Scientific Meeting at the Hong Kong Convention and Exhibition Centre on 24 March, fostering a platform for collaboration among leading experts in respiratory medicine.

Professor Morice’s presentation, part of the ‘Symposium on Airway Diseases’ morning session took place alongside esteemed colleagues like Professor Peter Calverley, highlighting developments in predicting and preventing Chronic Obstructive Pulmonary Disease Exacerbations.

 

Sign up

Subscribe To Our Email Newsletter

Be the first to know about EXCLUSIVE discount offers and the latest research into reflux.

You have Successfully Subscribed!